RAC
Click for more information
0.00% $1.66 race oncology ltd

Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-11

  1. Davisite
    19,192 Posts.
    lightbulb Created with Sketch. 6197
    clock Created with Sketch.
    30/07/24
    18:15
    Post #: 74987937
    Nothing hugely new in the announcement due to the security situation in Israel making it impossible to treat any more patients, but it is worth emphasising that the trial was successful in meeting its primary endpoint. In a disease as terrible as AML any success should be cherished.
    RAC Price at posting: $1.62 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 58  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
PV1 Provaris updates on progress with Uniper under hydrogen MOU – not long after interesting ASX response
right-arrow Created with Sketch.
GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.66 		Change
0.000(0.00%) 		Mkt cap ! $282.8M
Open High Low Value Volume
$1.68 $1.68 $1.62 $102.7K 62.79K

Buyers (Bids)

No. Vol. Price($)
1 359 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.66 249 1
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.